BD India Launches Rapid Molecular Technique for Detecting Multidrug-resistant Tuberculosis (MDR-TB) and other Infectious Diseases

To enable clinicians to rapidly test for TB and multidrug resistance as a first-line test, BD Diagnostics, a segment of BD Lifesciences (Becton, Dickinson, and Company), today introduced the BD MAX™ molecular diagnostic system and availability of the BD MAX™…